Home
Contact Us
About Us
Advertise
Biotech
Finance
Tech News
Disclaimer
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
BioPharmaJournal
Home
Contact Us
About Us
Advertise
Biotech
CymaBay Therapeutics Inc (NASDAQ: CBAY) Announces Promising Seladelpar Data In Treatment…
Chimerix Inc (NASDAQ: CMRX) Receives $25.3 Million Procurement Contract For TEMBEXA
Regulus Therapeutics Inc (NASDAQ: RGLS) Pleased after FDA Approved its Orphan…
Ocugen Inc (NASDAQ: OCGN) Announces the Successful Publication of Positive Outcomes…
Brickell Biotech Inc (NASDAQ: BBI) Announces Dosing of First Subject with…
Finance
Why Your Body Needs Nitric Oxide Boost Beets For More Energy…
Top Beer Stocks for the Recession-Proof Portfolio (BUD, KEGS, SAM, TAP,…
Cutting Edge Power announces an all-new version of its popular Smart…
Lucid Group Inc (NASDAQ:LCID) Poised for Action as New Catalysts Mount
Galera Therapeutics Inc. (NASDAQ: GRTX) Announced Updated Findings Of Phase 3…
Tech News
Aehr Test Systems (NASDAQ: AEHR) Receives an Order of $10.8 Million…
Tauriga Sciences Inc (OTCMKTS:TAUG) Could React on New Aegea Rapid Test…
Micro and Macro Tailwinds Converge for KULR
ISWH and the Rebirth of the Crypto Cycle
Disclaimer
Home
Biotech
Biotech
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
CymaBay Therapeutics Inc (NASDAQ: CBAY) Announces Promising Seladelpar Data In Treatment of Primary Biliary Cholangitis
Gavins Felicity
-
July 5, 2022
Chimerix Inc (NASDAQ: CMRX) Receives $25.3 Million Procurement Contract For TEMBEXA
Regulus Therapeutics Inc (NASDAQ: RGLS) Pleased after FDA Approved its Orphan Drug Designation RGLS8429
Ocugen Inc (NASDAQ: OCGN) Announces the Successful Publication of Positive Outcomes of COVID-19 Vaccine Trial for Children
Brickell Biotech Inc (NASDAQ: BBI) Announces Dosing of First Subject with its BBI-02
Cronos Group Inc (NASDAQ: CRON) and Ginkgo Bioworks Holdings Inc (NYSE:...
Gavins Felicity
-
June 27, 2022
0
Caribou Biosciences Inc (NASDAQ: CRBU) Unveils More Positive Initial Data Emanating...
Gavins Felicity
-
June 24, 2022
0
MEI Pharma Inc (NASDAQ: MEIP) and Kyowa Kirin Announce Clinical Data...
Gavins Felicity
-
June 23, 2022
0
Amarin Corporation plc (NASDAQ: AMRN) Applauds VAZKEPA’S Recommendation from United Kingdom’s...
Gavins Felicity
-
June 22, 2022
0
Fulcrum Therapeutics, Inc (NASDAQ: FULC) Says the Unveiled Proof-Of-Concept For FTX-6058...
Gavins Felicity
-
June 21, 2022
0
Cogent Biosciences Inc (NASDAQ: COGT) says The Ongoing Phase 2 APEX...
Gavins Felicity
-
June 20, 2022
0
Bristol-Myers Squibb Co (NYSE: BMY) Announces Plan to Purchase Turning Point...
Gavins Felicity
-
June 17, 2022
0
The U.S FDA Announces That Novavax, Inc. (NASDAQ: NVAX) is Effective...
Gavins Felicity
-
June 16, 2022
0
The FDA Has Increased The Review Time For Amylyx Pharmaceuticals Inc’s...
Gavins Felicity
-
June 15, 2022
0
Curis, Inc. (NASDAQ: CRIS) Will Present Data on Its TakeAim Leukaemia...
Gavins Felicity
-
June 14, 2022
0
1
2
3
...
153
Page 1 of 153
Recent Post
CymaBay Therapeutics Inc (NASDAQ: CBAY) Announces Promising Seladelpar Data In Treatment...
Gavins Felicity
-
July 5, 2022
0
CymaBay Therapeutics Inc (NASDAQ: CBAY) has announced the presentation of promising seladelpar findings in primary biliary cholangitis (PBC) patients at The International Liver Congress...
Chimerix Inc (NASDAQ: CMRX) Receives $25.3 Million Procurement Contract For TEMBEXA
July 4, 2022
Regulus Therapeutics Inc (NASDAQ: RGLS) Pleased after FDA Approved its Orphan...
July 1, 2022
Cannabis Stocks Deeply Oversold with Big Growth Ahead (TLRY, SGMD, OGI,...
June 30, 2022
Ocugen Inc (NASDAQ: OCGN) Announces the Successful Publication of Positive Outcomes...
June 30, 2022